Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China · Delayed Price · Currency is CNY

0.3700

-0.0100 (-2.63%)

Inactive · Last trade price on Jul 16, 2026

SHE:002898 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	618.17	518.76	263.57	310.63	264.19	247.08
Revenue Growth	149.09%	96.82%	-15.15%	17.58%	6.93%	104.73%
Gross Profit	48.23	56.99	86.78	139.52	136.35	160.37
Operating Income	-45.3	-42.7	-22.72	13.38	-42.44	-25.99
Net Income	-129.12	-121.17	-33.15	9.53	-37.31	-23.34
Earnings Per Share	-0.73	-0.69	-0.19	0.05	-0.21	-0.13
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Pharmaceutical Industry	157.58	261.06	303.51	261.14	244.05
Electronics Industry	359.25	-	-	-	-
Unallocated Other	1.93	2.51	7.12	3.05	3.03
Total	518.76	263.57	310.63	264.19	247.08

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	29.21	61.02	48.84	89.26	72.27	113.31
Total Debt	115.68	124.26	165.09	127.42	143.43	173.05
Net Cash (Debt)	-86.48	-63.24	-116.25	-38.16	-71.16	-59.74
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.49	-0.36	-0.66	-0.22	-0.40	-0.34

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	15.89	19.06	-38.86	35.71	14.12	35.46
Capital Expenditures	-21.82	-23.35	-34.67	-30.58	-23.94	-31.47
Free Cash Flow	-5.93	-4.29	-73.53	5.13	-9.82	3.99
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	7.80%	10.99%	32.93%	44.91%	51.61%	64.91%
Operating Margin	-7.33%	-8.23%	-8.62%	4.31%	-16.06%	-10.52%
Pretax Margin	-19.04%	-22.15%	-13.25%	7.20%	-11.23%	-5.57%
Profit Margin	-20.89%	-23.36%	-12.58%	3.07%	-14.12%	-9.45%
FCF Margin	-0.96%	-0.83%	-27.90%	1.65%	-3.72%	1.61%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.020
Dividend Per Share Growth	-
Dividend Yield	0.14%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	257.90	-	-
Forward PE	-	53.89	53.89	53.89	53.89	53.89
P/FCF Ratio	-	-	-	479.45	-	461.13
PS Ratio	0.11	4.62	6.42	7.92	8.09	7.44